Literature DB >> 16499261

Using tuberculosis suspects to identify patients eligible for antiretroviral treatment.

L Munthali1, J N Mwaungulu, K Munthali, C Bowie, A C Crampin.   

Abstract

SETTING: A district in rural sub-Saharan Africa with a recently introduced antiretroviral (ARV) programme. The population has high human immunodeficiency virus (HIV) prevalence and high tuberculosis (TB) incidence.
OBJECTIVE: To determine the prevalence of HIV and acquired immune-deficiency syndrome (AIDS) related symptoms in people presenting with chronic cough who are not diagnosed with TB.
DESIGN: A cross-sectional survey of TB suspects.
METHODS: Patients with chronic cough were recruited from out-patient facilities. After standard diagnostic procedures and providing informed consent, they received counselling and testing for HIV, and were interviewed and examined with respect to staging criteria for HIV/AIDS. Suspects were followed up for 3 months after the end of the recruitment period to allow for delayed diagnosis of TB.
RESULTS: Of 145 suspects, 79% had not been diagnosed with TB by the end of the follow-up period. Of these, 108 (95%) agreed to HIV testing and 61 (56%) were HIV-positive. More than half of these were eligible for ARV treatment (Stage III or IV disease) under national programme criteria.
CONCLUSION: Established chronic cough clinics are a useful setting for recruitment of patients to ARV clinics. Attendees should be offered HIV testing and simple clinical screening to identify those who should be referred for ARV treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16499261

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  17 in total

1.  What has Karonga taught us? Tuberculosis studied over three decades.

Authors:  A C Crampin; J R Glynn; P E M Fine
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373

2.  Predictors of HIV testing among patients with tuberculosis in North West Ethiopia: a case-control study.

Authors:  Animut Ayenew; Abenet Leykun; Robert Colebunders; Amare Deribew
Journal:  PLoS One       Date:  2010-03-15       Impact factor: 3.240

3.  Assessing the accessibility of HIV care packages among tuberculosis patients in the Northwest Region, Cameroon.

Authors:  Nwarbébé Barnabas Njozing; San Sebastian Miguel; Pius Muffih Tih; Anna-Karin Hurtig
Journal:  BMC Public Health       Date:  2010-03-12       Impact factor: 3.295

4.  Are HIV-positive presumptive tuberculosis patients without tuberculosis getting the care they need in Zimbabwe?

Authors:  R A Dlodlo; Z E Hwalima; S Sithole; K C Takarinda; K Tayler-Smith; A D Harries
Journal:  Public Health Action       Date:  2015-11-12

5.  Impact of changing diagnostic criteria for smear-positive tuberculosis: a cohort study in Malawi.

Authors:  O Koole; L Munthali; B Mhango; J Mpunga; J R Glynn; A C Crampin
Journal:  Int J Tuberc Lung Dis       Date:  2014-07       Impact factor: 2.373

6.  The Sensitivity and Specificity of Loop-Mediated Isothermal Amplification (LAMP) Assay for Tuberculosis Diagnosis in Adults with Chronic Cough in Malawi.

Authors:  Marriott Nliwasa; Peter MacPherson; Palesa Chisala; Mercy Kamdolozi; McEwen Khundi; Kruger Kaswaswa; Mphatso Mwapasa; Chisomo Msefula; Hojoon Sohn; Clare Flach; Elizabeth L Corbett
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

7.  Feasibility and effectiveness of provider initiated HIV testing and counseling of TB suspects in Vizianagaram district, South India.

Authors:  Shanta Achanta; Ajay M V Kumar; Sharath Burugina Nagaraja; Jyoti Jaju; Srinivas Rao Motta Shamrao; Ramakrishna Uppaluri; Rama Rao Tekumalla; Devesh Gupta; Ashok Kumar; Srinath Satyanarayana; Puneet K Dewan
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

8.  Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study.

Authors:  Myrsini Kaforou; Victoria J Wright; Tolu Oni; Neil French; Suzanne T Anderson; Nonzwakazi Bangani; Claire M Banwell; Andrew J Brent; Amelia C Crampin; Hazel M Dockrell; Brian Eley; Robert S Heyderman; Martin L Hibberd; Florian Kern; Paul R Langford; Ling Ling; Marc Mendelson; Tom H Ottenhoff; Femia Zgambo; Robert J Wilkinson; Lachlan J Coin; Michael Levin
Journal:  PLoS Med       Date:  2013-10-22       Impact factor: 11.069

9.  HIV screening among TB patients and co-trimoxazole preventive therapy for TB/HIV patients in Addis Ababa: facility based descriptive study.

Authors:  Amenu Wesen Denegetu; Bethabile Lovely Dolamo
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

10.  HIV Testing among Patients with Presumptive Tuberculosis: How Do We Implement in a Routine Programmatic Setting? Results of a Large Operational Research from India.

Authors:  Ajay Mv Kumar; Devesh Gupta; Ashok Kumar; R S Gupta; Avinash Kanchar; Raghuram Rao; Suresh Shastri; M D Suryakanth; Chethana Rangaraju; Balaji Naik; Deepak K Guddemane; Prashant Bhat; Achuthan Sreenivas Nair; Anthony David Harries; Puneet Dewan
Journal:  PLoS One       Date:  2016-05-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.